Klee Justin B. — SEC insider filings

SEC reporting owner CIK 1898314. 25 insider filings on record with FilingPulse; latest filed 2026-11-12.

Transaction summary — filings shown

Covers all 25 filings on record, filed 2022-01-10 to 2026-11-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Amylyx Pharmaceuticals, Inc. (AMLX)Co-Chief Executive Officer, Director25—22 legs · 531,068 sh · $10,804,94125

Insider filings — Klee Justin B.

FiledFormIssuerReported transactionsSource
2026-11-124Amylyx Pharmaceuticals, Inc. (AMLX)Sale (S): 37,483 @ $29.39 · Sale (S): 62,517 @ $30.11EDGAR
2026-09-144Amylyx Pharmaceuticals, Inc. (AMLX)Sale (S): 29,025 @ $32.13 · Sale (S): 1,439 @ $33.16EDGAR
2026-08-204Amylyx Pharmaceuticals, Inc. (AMLX)Grant/award (A): 60,039 @ $0EDGAR
2026-03-094Amylyx Pharmaceuticals, Inc. (AMLX)Grant/award (A): 248,865 @ $0 · Grant/award (A): 373,295 (derivative) @ $0EDGAR
2026-03-044Amylyx Pharmaceuticals, Inc. (AMLX)Sale (S): 29,282 @ $14.47EDGAR
2026-02-044Amylyx Pharmaceuticals, Inc. (AMLX)Sale (S): 15,500 @ $14.69EDGAR
2026-01-204Amylyx Pharmaceuticals, Inc. (AMLX)Option exercise (M): 197,153 @ $7.57 · Sale (S): 136,193 @ $13.58 · Option exercise (M): 2,847 @ $7.57 · Sale (S): 1,995 @ $13.89 · Option exercise (M): 197,153 (derivative) @ $0 · Option exercise (M): 2,847 (derivative) @ $0EDGAR
2026-01-084Amylyx Pharmaceuticals, Inc. (AMLX)Sale (S): 7,715 @ $11.09EDGAR
2025-10-024Amylyx Pharmaceuticals, Inc. (AMLX)Sale (S): 29,775 @ $14.37 · Sale (S): 200 @ $15.01EDGAR
2025-04-024Amylyx Pharmaceuticals, Inc. (AMLX)Sale (S): 21,490 @ $3.46EDGAR
2025-03-104Amylyx Pharmaceuticals, Inc. (AMLX)Grant/award (A): 180,118 @ $0 · Grant/award (A): 270,177 (derivative) @ $0EDGAR
2025-03-054Amylyx Pharmaceuticals, Inc. (AMLX)Sale (S): 4,595 @ $3.15EDGAR
2025-02-064Amylyx Pharmaceuticals, Inc. (AMLX)Option exercise (M): 36,310 @ $1.57 · Option exercise (M): 36,310 (derivative) @ $0EDGAR
2025-02-054Amylyx Pharmaceuticals, Inc. (AMLX)Sale (S): 11,855 @ $3.47EDGAR
2025-01-084Amylyx Pharmaceuticals, Inc. (AMLX)Sale (S): 7,471 @ $4.04EDGAR
2024-11-064Amylyx Pharmaceuticals, Inc. (AMLX)Option exercise (M): 63,690 @ $1.57 · Option exercise (M): 63,690 (derivative) @ $0EDGAR
2024-10-024Amylyx Pharmaceuticals, Inc. (AMLX)Sale (S): 18,589 @ $3.20EDGAR
2024-04-184Amylyx Pharmaceuticals, Inc. (AMLX)Grant/award (A): 179,850 @ $0 · Grant/award (A): 380,000 (derivative) @ $0EDGAR
2024-03-074Amylyx Pharmaceuticals, Inc. (AMLX)Sale (S): 4,135 @ $18.73EDGAR
2024-02-284Amylyx Pharmaceuticals, Inc. (AMLX)Grant/award (A): 126,667 @ $0 · Grant/award (A): 190,000 (derivative) @ $0EDGAR
2024-01-114Amylyx Pharmaceuticals, Inc. (AMLX)Sale (S): 5,841 @ $16.33EDGAR
2023-03-204Amylyx Pharmaceuticals, Inc. (AMLX)Sale (S): 96,555 @ $31.84 · Sale (S): 3,445 @ $32.48 · Grant/award (A): 50,000 @ $0 · Grant/award (A): 225,000 (derivative) @ $0EDGAR
2023-01-104Amylyx Pharmaceuticals, Inc. (AMLX)Sale (S): 4,122 @ $36.08 · Sale (S): 1,846 @ $36.79EDGAR
2022-05-064Amylyx Pharmaceuticals, Inc. (AMLX)Option exercise (M): 334,520 @ $0.37 · Option exercise (M): 334,520 (derivative) @ $0EDGAR
2022-01-104Amylyx Pharmaceuticals, Inc. (AMLX)Conversion (C): 4,870 @ $0 · Grant/award (A): 75,000 @ $0 · Conversion (C): 4,870 (derivative) @ $0 · Grant/award (A): 337,500 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-11-20 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1898314 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs